Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Maurizio Di Bonito(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 112
Related Papers
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
|Journal of Cancer|2017|51
Increased HOX C13 expression in metastatic melanoma progression
|Journal of Translational Medicine|2012|43